[1] LI R, ZHOU R, ZHANG J. Function of PM2.5 in the pathogenesis of lung cancer and chronic airway inflammatory diseases[J]. Oncol Lett, 2018, 15(5):7506-7514. [2] FAN J, LI S, FAN C, et al. The impact of PM2.5 on asthma emergency department visits:a systematic review and meta-analysis[J]. Environ Sci Pollut Res Int, 2016, 23(1):843-850. [3] MIRABELLI M C, VAIDYANATHAN A, FLANDERS W D, et al. Outdoor PM2.5, ambient air temperature, and asthma symptoms in the past 14 days among adults with active asthma[J]. Environ Health Perspect, 2016, 124(12):1882-1890. [4] 王冰玉, 蔡颖, 郑凯, 等. PM2.5对HBE细胞致癌致突变相关基因表达的影响[J]. 癌变·畸变·突变, 2020, 32(1):33-38, 42. [5] 王冰玉, 郑凯, 徐新云, 等. PM2.5对支气管上皮细胞DNA损伤作用研究[J]. 癌变·畸变·突变, 2019, 31(6):469-473, 497. [6] 郑凯, 王冰玉, 徐新云, 等. 深圳和太原PM2.5样品致突变作用研究[J]. 癌变·畸变·突变, 2019, 31(6):483-487. [7] LI P, WANG J P, GUO F J, et al. A novel inhibitory role of microRNA-224 in particulate matter 2.5-induced asthmatic mice by inhibiting TLR2[J]. J Cell Mol Med, 2020, 24(5):3040-3052. [8] LIU C, GUO H, CHENG X, et al. Exposure to airborne PM2.5 suppresses microRNA expression and deregulates target oncogenes that cause neoplastic transformation in NIH3T3 cells[J]. Oncotarget, 2015, 6(30):29428-29439. [9] BRONEVETSKY Y, MARK ANSEL K. Regulation of miRNA biogenesis and turnover in the immune system[J]. Immunol Rev, 2013, 253(1):304-316. [10] YANG D, MA M Y, ZHOU W Q, et al. Inhibition of miR-32 activity promoted EMT induced by PM2.5 exposure through the modulation of the Smad1-mediated signaling pathways in lung cancer cells[J]. Chemosphere, 2017, 184:289-298. [11] 黄怡颖, 张健. miRNA-17-5p、miRNA-103-3p及miRNA-144-3p在急性缺血性脑卒中中的表达及诊断价值研究[J]. 国际检验医学杂志, 2020, 41(9):1105-1108. [12] RUPAIMOOLE R, SLACK F J. microRNA therapeutics:towards a new era for the management of cancer and other diseases[J]. Nat Rev Drug Discov, 2017, 16(3):203-222. [13] 孙云菊, 张星, 陆幼波, 等. miRNA-380-5p在乳腺癌细胞增殖和凋亡中的作用机制[J]. 中国妇幼保健, 2020, 35(11):2097-2100. [14] ALI SYEDA Z, LANGDEN S S S, MUNKHZUL C, et al. Regulatory mechanism of microRNA expression in cancer[J]. Int J Mol Sci, 2020, 21(5):1723. [15] 周学, 杜宜兰, 金萍, 等. 癌症相关microRNA与靶基因的生物信息学分析[J]. 遗传, 2015, 37(9):855-864. [16] 侯天芳, 廖纪萍, 马元元, 等. 大气细颗粒物暴露后小鼠肺组织microRNA差异表达谱芯片分析[J]. 生态毒理学报, 2018, 13(1):138-146. [17] MA H P, KONG W X, LI X Y, et al. miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR[J]. Oncol Rep, 2019, 41(3):1549-1559. [18] WANG Z, LI J J, LONG X B, et al. MRPS16 facilitates tumor progression via the PI3K/AKT/Snail signaling axis[J]. J Cancer, 2020, 11(8):2032-2043. [19] PRADHAN R, SINGHVI G, DUBEY S K, et al. MAPK pathway:a potential target for the treatment of non-small-cell lung carcinoma[J]. Futur Med Chem, 2019, 11(8):793-795. [20] SOLEIMANI A, RAHMANI F, SAEEDI N, et al. The potential role of regulatory microRNAs of RAS/MAPK signaling pathway in the pathogenesis of colorectal cancer[J]. J Cell Biochem, 2019, 120(12):19245-19253. [21] YUE L, GUO J. lncRNA TUSC7 suppresses pancreatic carcinoma progression by modulating miR-371a-5p expression[J]. J Cell Physiol, 2019, 234(9):15911-15921. [22] ZHU L, WANG Z, FAN Q, et al. microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS[J]. Oncol Rep, 2014, 31(1):280-286. [23] LI K, ZHU X R, CHEN X H, et al. microRNA-27a-3p promotes epithelial-mesenchymal transition by targeting NOVA alternative splicing regulator 1 in gastric cancer[J]. Mol Med Report, 2020:21(3):1615-1622. [24] LU Q, SHAN S, LI Y, et al. Long noncoding RNA SNHG1 promotes non-small cell lung cancer progression by up-regulating MTDH via sponging miR-145-5p[J]. Faseb J, 2018, 32(7):3957-3967. [25] ZHANG Y, TA W, SUN P, et al. Diagnostic and prognostic significance of serum miR-145-5p expression in glioblastoma[J]. Int J Clin Exp Pathol, 2019, 12(7):2536. [26] DONG M J, XIE Y Y, XU Y D. miR-7-5p regulates the proliferation and migration of colorectal cancer cells by negatively regulating the expression of Krüppel-like factor 4[J]. Oncol Lett, 2019, 17(3):3241-3246. [27] WANG Q, LIU S Y, ZHAO X T, et al. MiR-372-3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma[J]. Cancer Med, 2017, 6(6):1323-1330. [28] YANG Z Q, WU C G, CHENG Y X. Prognostic value of microRNA-133a expression and its clinicopathologic significance in non-small cell lung cancer:a comprehensive study based on meta-analysis and the TCGA database[J]. Onkologie, 2018, 41(12):762-768. [29] 薛无涯, 王舰梅, 夏天, 等. miR-204-5p对结直肠癌细胞增殖、侵袭、迁移及上皮间质转化的影响[J]. 西南医科大学学报, 2018, 41(2):104-110. [30] CHEN X, XU X, PAN B, et al. miR-150-5p suppresses tumor progression by targeting VEGFA in colorectal cancer[J]. Aging (Albany NY), 2018, 10(11):3421-3437. [31] CAO H Y, XIAO C H, LU H J, et al. MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3[J]. Eur Rev Med Pharmacol Sci, 2019, 23(15):6478-6485. [32] PERVAIZ A, ZEPP M, MAHMOOD S, et al. CCR5 blockage by maraviroc:a potential therapeutic option for metastatic breast cancer[J]. Cell Oncol (Dordr), 2019, 42(1):93-106. |